Liang Howard — SEC insider filings
SEC reporting owner CIK 1663427. 8 insider filings on record with FilingPulse; latest filed 2026-10-29.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2020-09-16 to 2026-10-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 34 legs across 7 filings — 135,482 shares, $34,125,952 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 24,842 shares @ $230.51 ($5,726,245) in BeiGene, Ltd., filed 2020-12-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeiGene, Ltd. (BGNE) | CFO & Chief Strategy Officer | 7 | — | 34 legs · 135,482 sh · $34,125,952 | 11 |
| Bambusa Therapeutics, Inc. (BBTX) | Director | 1 | — | — | — |
Insider filings — Liang Howard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-29 | 3 | Bambusa Therapeutics, Inc. (BBTX) | Holdings only — no transactions reported | EDGAR |
| 2021-06-30 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 446 @ $365 | EDGAR |
| 2021-06-21 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 486 @ $325.89 | EDGAR |
| 2021-06-09 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 650 @ $354.16 | EDGAR |
| 2021-01-19 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 1,400 @ $6.50 · Sale (S): 1,100 @ $344.28 · Sale (S): 300 @ $345.15 · Option exercise (M): 12,600 @ $6.50 · Sale (S): 6,994 @ $344.38 · Sale (S): 5,606 @ $345.54 · +2 more | EDGAR |
| 2020-12-16 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 1,405,300 @ $0.50 · Option exercise (M): 91,900 @ $6.50 · Sale (S): 4,100 @ $225.24 · Sale (S): 6,203 @ $226.40 · Sale (S): 15,062 @ $227.08 · Sale (S): 7,500 @ $227.72 · +7 more | EDGAR |
| 2020-10-07 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 14,000 @ $6.50 · Sale (S): 817 @ $293.26 · Sale (S): 1,415 @ $294.92 · Sale (S): 568 @ $295.73 · Sale (S): 500 @ $296.47 · Sale (S): 1,200 @ $297.98 · +7 more | EDGAR |
| 2020-09-16 | 4 | BeiGene, Ltd. (BGNE) | Option exercise (M): 14,000 @ $6.50 · Sale (S): 400 @ $247.46 · Sale (S): 1,681 @ $248.93 · Sale (S): 6,478 @ $249.97 · Sale (S): 3,157 @ $250.71 · Sale (S): 2,181 @ $251.95 · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1663427 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs